Department of Anesthesiology, Washington University School of Medicine, St. Louis, MO..
Center for Thoracic Outlet Syndrome, Department of Surgery, Section of Vascular Surgery, Washington University School of Medicine, St. Louis, MO.
Ann Vasc Surg. 2021 Nov;77:236-242. doi: 10.1016/j.avsg.2021.05.067. Epub 2021 Aug 26.
The purpose of this study was to determine if single injection erector spinae plane blocks are associated with improved pain control, opioid use, numbness, length of stay, or patient satisfaction compared to intraoperatively placed continuous perineural infusion of local anesthetic after decompression of neurogenic thoracic outlet syndrome.
This is a retrospective cohort study at a tertiary academic center of eighty patients that underwent supraclavicular decompression for thoracic outlet syndrome between May 2019 and January 2020. Forty consecutive patients treated with single-injection preoperative erector spinae plane blocks were retrospectively compared to 40 age- and gender-matched controls treated with continuous perineural infusion.
The primary outcome of mean pain scores was not significantly different between the erector spinae and perineural infusion groups over the three-day study period (4.2-5.3 vs 3.0-5.1 P=0.08). On post-operative day 0, mean pain scores were significantly higher in the erector spinae group (4.2 vs 3.0, P=0.02). While statistically significant, the score was still lower in the erector spinae group on day 0 than on day 1,2, or 3 in either group. Opioid use, nausea, length of stay and patient satisfaction were also similar. Upper extremity numbness was significantly less severe in the erector spinae group (36% vs 73% moderate-extreme, P=0.03) at 6-month follow-up.
Seventy-two-hour perineural local anesthetic infusion did not provide superior analgesia compared to preoperative single-injection erector spinae blocks. Furthermore, there was significantly less long-term postoperative numbness associated with erector spinae blocks compared to perineural local anesthetic infusion.
本研究旨在确定与术中放置连续神经周围局部麻醉浸润相比,单次注射竖脊肌平面阻滞是否与改善疼痛控制、阿片类药物使用、麻木、住院时间或患者满意度相关,用于治疗神经源性胸廓出口综合征减压后。
这是在一家三级学术中心进行的回顾性队列研究,共纳入 80 例 2019 年 5 月至 2020 年 1 月期间因胸廓出口综合征接受锁骨上减压术的患者。连续 40 例接受单次术前竖脊肌平面阻滞的患者与 40 例年龄和性别匹配的接受连续神经周围浸润的患者进行回顾性比较。
在为期三天的研究期间,竖脊肌和神经周围浸润组的主要疼痛评分平均值没有显著差异(4.2-5.3 对 3.0-5.1,P=0.08)。在术后第 0 天,竖脊肌组的平均疼痛评分明显更高(4.2 对 3.0,P=0.02)。虽然具有统计学意义,但竖脊肌组在第 0 天的评分仍低于第 1、2 或 3 天两组。阿片类药物使用、恶心、住院时间和患者满意度也相似。在 6 个月随访时,竖脊肌组上肢麻木明显较轻(36%对 73%中度-重度,P=0.03)。
72 小时神经周围局部麻醉浸润并未提供优于术前单次注射竖脊肌平面阻滞的镇痛效果。此外,与神经周围局部麻醉浸润相比,竖脊肌阻滞与术后长期麻木显著减少相关。